Trials / Sponsors / Tasly Tianjin Biopharmaceutical Co., Ltd.
Tasly Tianjin Biopharmaceutical Co., Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Ana Hepatitis B Virus (HBV) | Phase 2 | 2019-12-10 |
| Unknown | Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T6 Advanced Malignant Solid Tumors | Phase 1 / Phase 2 | 2019-11-20 |
| Completed | Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients Hepatitis B Virus (HBV) | Phase 1 | 2018-01-08 |